Abliva AB - Invidious

Abliva AB

Abliva – Delivering mitochondrial health
Abliva discovers and develops medicines for the treatment of mitochondrial diseases. These rare and often very severe diseases occur when the cell’s energy provider, the mitochondria, do not function properly. The company has prioritized two projects. KL1333, a powerful regulator of the essential co-enzymes NAD⁺ and NADH, is in clinical trials. NV354, an energy replacement therapy, has completed preclinical development. Abliva is based in Lund, Sweden, and is since spring 2025 a member of Dutch Pharming Group N.V.

View channel on YouTube

Switch Invidious Instance

Videos

newest

oldest

popular

1:01

Abliva - Mitochondrial disease inheritance

Abliva AB

Shared 1 year ago

86 views

1:14

Abliva - Light Up for Mito during World Mitochondrial Disease Week 2024

Abliva AB

Shared 1 year ago

208 views

3:24

Abliva - CEO Ellen Donnelly talks about the positive interim analysis in the FALCON study

Abliva AB

Shared 1 year ago

299 views

1:40

Join Abliva - World Mitochondrial Disease Week 2024 - Meet Regina, mito patient

Abliva AB

Shared 1 year ago

152 views

1:06:30

Abliva - KOL Event on KL1333 in Primary Mitochondrial Disease, May 21, 2024

Abliva AB

Shared 1 year ago

322 views

2:42

Abliva - Developing the PROMIS Fatigue Mitochondrial Disease Short Form

Abliva AB

Shared 2 years ago

219 views

2:20

Abliva - Participating in the FALCON Study - World Mitochondrial Disease Week 2023

Abliva AB

Shared 2 years ago

134 views

2:31

Abliva - Introducing the FALCON study - World Mitochondrial Disease Week

Abliva AB

Shared 2 years ago

509 views

2:16

Abliva - Designing Therapies for Mitochondrial Disease - World Mitochondrial Disease Week

Abliva AB

Shared 2 years ago

451 views

1:08

Abliva participates in World Mitochondrial Disease Week 2023

Abliva AB

Shared 2 years ago

99 views

0:28

Abliva - World Mitochondrial Disease Week 2023

Abliva AB

Shared 2 years ago

115 views

3:46

Abliva - Primary Mitochondrial Disease and NAD+/NADH

Abliva AB

Shared 2 years ago

888 views

2:16

Abliva - About Lead Candidate KL1333

Abliva AB

Shared 2 years ago

1.1K views

5:19

Abliva - Mitochondrial Disease in Children - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

237 views

3:47

Abliva - A Patient-Centric Approach to Drug Development - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

130 views

3:43

Abliva - Abliva’s upcoming Phase 2/3 study with KL1333 - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

219 views

3:52

Abliva - Drug Development in Mito Disease - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

125 views

9:35

Abliva - Living with Mitochondrial Disease: full interview - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

276 views

4:55

Abliva - Living with Mitochondrial Disease - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

608 views

2:32

Abliva - Introducing Mitochondrial “Mito” Disease - World Mitochondrial Disease Week 2022

Abliva AB

Shared 3 years ago

160 views

0:28

Abliva is preparing for this year's World Mitochondrial Disease Week - 18 -24 September 2022

Abliva AB

Shared 3 years ago

86 views

5:49

Abliva - Developing Drugs in Rare Diseases - Orphan Drug Designation

Abliva AB

Shared 4 years ago

225 views

2:30

Abliva - KL1333 and the upcoming Phase 2/3-study

Abliva AB

Shared 4 years ago

373 views

3:41

Abliva - Drug Development - Mito Disease

Abliva AB

Shared 4 years ago

279 views

2:51

Abliva - Living with Mito Disease

Abliva AB

Shared 4 years ago

188 views

3:39

Abliva - Designing Therapies for Mito Disease

Abliva AB

Shared 4 years ago

340 views

2:36

Abliva - Introducing Mitochondrial “Mito” Disease

Abliva AB

Shared 4 years ago

392 views

5:29

KL1333 (Abliva drug candidate) e-poster pres, Dr. Pitceathly, UMDF Mitochondrial Medicine 2021

Abliva AB

Shared 4 years ago

468 views

8:25

CEO comment from Abliva's Annual General Meeting 2021

Abliva AB

Shared 4 years ago

354 views

2:23

Abliva's CMO Magnus Hansson presents poster lightning talk at Mitochondrial Medicine 2020

Abliva AB

Shared 4 years ago

117 views

7:08

Abliva's CEO Ellen Donnelly presents the company at Swiss Nordic Bio 2021

Abliva AB

Shared 4 years ago

612 views

16:02

Interview: Frank J. Sasinowski, US Consultant specializing in regulatory matters for orphan drugs

Abliva AB

Shared 4 years ago

180 views

10:24

Interview with Elja van der Veer, Founder and Chair of International Mito Patients (IMP)

Abliva AB

Shared 5 years ago

85 views

1:49:40

Abliva's Mitochondria Day 16 Sep 2020 (Subtitled in English/Swedish)

Abliva AB

Shared 5 years ago

258 views

4:43

Abliva - Interview with father of a little girl with primary mitochondrial disease

Abliva AB

Shared 5 years ago

491 views

2:48

Abliva Patient Interview - MELAS - primary mitochondrial disease

Abliva AB

Shared 5 years ago

3.9K views

1:36

Abliva – What is mitochondrial disease?

Abliva AB

Shared 5 years ago

3.5K views

1:19:19

Abliva Capital Markets Day, 23 June 2020

Abliva AB

Shared 5 years ago

513 views

16:47

VD-anförande årsstämma 2020/CEO presentation AGM 2020 - in Swedish

Abliva AB

Shared 5 years ago

257 views